[HTML][HTML] Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

AA Bhat, S Nisar, S Maacha, TC Carneiro-Lobo… - Molecular cancer, 2021 - Springer
Esophageal cancer (EC) is a disease often marked by aggressive growth and poor
prognosis. Lack of targeted therapies, resistance to chemoradiation therapy, and distant …

Targeting CXCL12/CXCR4 axis in tumor immunotherapy

W Zhou, S Guo, M Liu, ME Burow… - Current medicinal …, 2019 - ingentaconnect.com
Chemokines, which have chemotactic abilities, are comprised of a family of small cytokines
with 8-10 kilodaltons. Chemokines work in immune cells by trafficking and regulating cell …

CXCR4 signaling in health and disease

T Pozzobon, G Goldoni, A Viola, B Molon - Immunology letters, 2016 - Elsevier
Chemokines and chemokine receptors regulate multiple processes such morphogenesis,
angiogenesis and immune responses. Among the chemokine receptors, CXCR4 stands out …

Imaging of CXC motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-pentixafor PET

AK Buck, A Haug, N Dreher, A Lambertini… - Journal of Nuclear …, 2022 - Soc Nuclear Med
In recent years, molecular imaging addressing the CXC motif chemokine receptor 4
(CXCR4) has increasingly been used in various clinical settings. Here, we aimed to assess …

Pathological roles of the homeostatic chemokine CXCL12

R Janssens, S Struyf, P Proost - Cytokine & growth factor reviews, 2018 - Elsevier
CXCL12 is a CXC chemokine that traditionally has been classified as a homeostatic
chemokine. It contributes to physiological processes such as embryogenesis, hematopoiesis …

Making sense of pharmacology: inverse agonism and functional selectivity

KA Berg, WP Clarke - International Journal of …, 2018 - academic.oup.com
Constitutive receptor activity/inverse agonism and functional selectivity/biased agonism are
2 concepts in contemporary pharmacology that have major implications for the use of drugs …

Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy

RL Sleightholm, BK Neilsen, J Li, MM Steele… - Pharmacology & …, 2017 - Elsevier
Chemokine networks regulate a variety of cellular, physiological, and immune processes.
These normal functions can become appropriated by cancer cells to facilitate a more …

Multifaceted role of chemokines in solid tumors: From biology to therapy

S Raza, S Rajak, A Tewari, P Gupta… - Seminars in cancer …, 2022 - Elsevier
Chemokines are small secretory chemotactic cytokines that control the directed migration of
immune cells. Chemokines are involved in both anti-and pro-tumorigenic immune …

[HTML][HTML] Quercetin inhibits breast cancer stem cells via downregulation of aldehyde dehydrogenase 1A1 (ALDH1A1), chemokine receptor type 4 (CXCR4), mucin 1 …

R Wang, L Yang, S Li, D Ye, L Yang, Q Liu… - … medical journal of …, 2018 - ncbi.nlm.nih.gov
Background Quercetin, nature's most common flavonoid, possesses anticarcinogenic
properties against various forms of cancer. The aim of this study was to investigate the effect …

[HTML][HTML] The signaling duo CXCL12 and CXCR4: chemokine fuel for breast cancer tumorigenesis

KA Zielińska, VL Katanaev - Cancers, 2020 - mdpi.com
Simple Summary Breast cancer remains the most common malignancy in women. In this
review, we explore the role of the CXCL12/CXCR4 pathway in breast cancer. We show that …